In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Molecular Devices buys Axon Instruments for $134.4mm

Executive Summary

Molecular Devices (bioanalytical measurement systems used in drug discovery) has acquired privately held Axon Instruments (microarray scanners) for about $134.4mm. It paid $0.1359 in cash and 0.00734 of an MD share for each outstanding Axon share, for a total of $68.7mm in cash, and 3.6mm common shares valued at $65.7mm.
Deal Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Drug Discovery Tools
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Intra-Biotech Deal
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies